Stahler A. Rachel's Insider Trades & SAST Disclosures

Stahler A. Rachel's most recent trade in Organon & Co. was a trade of 181,518 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 31, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Organon & Co.
Rachel A. Stahler Chief Information Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 181,518 181,518 - - Stock Option (right to buy)
Organon & Co.
Rachel A. Stahler Chief Information Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 36,937 36,937 - - Restricted Stock Units
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 8,200 74,313 - 0 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 8,200 16,401 - - Restricted Stock Units
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 6,555 6,555 - - Restricted Stock Units
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 6,555 78,059 - 0 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 3,579 0 - - Restricted Stock Units
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2025 3,579 78,993 - 0 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share. 31 Mar 2025 2,809 71,504 - 14.5 40,759 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share. 31 Mar 2025 2,645 75,414 - 14.5 38,379 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share. 31 Mar 2025 1,763 77,230 - 14.5 25,581 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2025 14,037 64,223 - 0 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.92 per share. 20 Feb 2025 5,142 59,081 - 14.9 76,719 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2025 2,571 61,652 - 0 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.29 per share. 20 Feb 2025 881 66,113 - 15.3 13,470 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Sep 2024 3,594 51,831 - 0 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.35 per share. 03 Sep 2024 1,645 50,186 - 20.4 33,476 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2024 3,049 49,282 - 0 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2024 3,049 0 - - Restricted Stock Units
Organon & Co.
Rachel A. Stahler Chief Information Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.61 per share. 04 May 2024 1,045 48,237 - 19.6 20,492 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 6,554 13,110 - - Restricted Stock Units
Organon & Co.
Rachel A. Stahler Chief Information Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2024 6,554 48,478 - 0 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2024 3,578 43,150 - 0 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2024 3,578 3,579 - - Restricted Stock Units
Organon & Co.
Rachel A. Stahler Chief Information Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.80 per share. 31 Mar 2024 2,245 46,233 - 18.8 42,206 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.80 per share. 31 Mar 2024 1,226 41,924 - 18.8 23,049 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2024 100,762 100,762 - - Stock Option (right to buy)
Organon & Co.
Rachel A. Stahler Chief Information Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2024 24,601 24,601 - - Restricted Stock Units
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 12,117 0 - - Restricted Stock Units
Organon & Co.
Stahler A. Rachel Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2024 12,117 43,898 - - Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.04 per share. 28 Feb 2024 4,326 39,572 - 18.0 78,041 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2023 12,895 0 - - Restricted Stock Units
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2023 12,895 36,199 - - Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.53 per share. 05 Aug 2023 4,418 31,781 - 21.5 95,120 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2023 3,046 24,348 - - Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2023 3,046 3,049 - - Restricted Stock Units
Organon & Co.
Rachel A. Stahler Chief Information Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.24 per share. 04 May 2023 1,044 23,304 - 24.2 25,307 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2023 70,610 70,610 - - Stock Option (right to buy)
Organon & Co.
Rachel A. Stahler Chief Information Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2023 19,664 19,664 - - Restricted Stock Units
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 3,578 22,528 - 0 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 3,578 7,157 - - Restricted Stock Units
Organon & Co.
Rachel A. Stahler Chief Information Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.09 per share. 31 Mar 2023 1,226 21,302 - 23.1 28,308 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2022 12,890 23,366 - - Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2022 12,890 12,890 - - Restricted Stock Units
Organon & Co.
Rachel A. Stahler Chief Information Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.41 per share. 05 Aug 2022 4,416 18,950 - 32.4 143,123 Common Stock
Neogenomics Inc.
Rachel A. Stahler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 15,556 21,335 (0%) 0% 0 Common Stock
Neogenomics Inc.
Rachel A. Stahler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 13,882 13,882 - - Stock Option (Right to Buy)
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2022 3,046 11,520 - - Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2022 3,046 3 - - Restricted Stock Units
Organon & Co.
Rachel A. Stahler Chief Information Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.44 per share. 04 May 2022 1,044 10,476 - 32.4 33,867 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 33,068 33,068 - - Stock Option (right to buy)
Organon & Co.
Rachel A. Stahler Chief Information Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 10,735 10,735 - - Restricted Stock Units
Organon & Co.
Rachel A. Stahler Chief Information Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2021 22,321 22,321 - - Stock Option (Right to Buy)
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2021 12,890 25,785 - - Restricted Stock Units
Organon & Co.
Rachel A. Stahler Chief Information Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.63 per share. 05 Aug 2021 12,890 12,890 - 28.6 369,041 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.63 per share. 05 Aug 2021 4,416 8,474 - 28.6 126,430 Common Stock
Organon & Co.
Rachel A. Stahler Chief Information Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2021 70,876 70,876 - - Stock Option (Right to Buy)
Organon & Co.
Rachel A. Stahler Chief Information Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2021 38,675 38,675 - - Restricted Stock Units
Organon & Co.
Rachel A. Stahler Chief Information Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2021 12,118 12,118 - - Restricted Stock Units
Organon & Co.
Rachel A. Stahler Chief Information Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2021 9,141 9,141 - - Restricted Stock Units
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades